Joint Formulary & PAD

Naproxen - Pain & inflammation - musculoskeletal

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Preferred
 

Status 2

Green (see narrative)
Formulations :
  • Effervescent tablets
  • Oral suspension
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important
Effervescent tablets and oral suspension are much more expensive and should be reserved for patients in whom ibuprofen suspension is not suitable. Reserve oral suspension for patients with sodium restriction or for children.
 

Status 3

Non Formulary
Formulations :
  • Gastro-resistant tablets
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :
Important
More expensive that standard tablets and offer no additional gastro-protection.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Naproxen
Indication :
Pain & inflammation - musculoskeletal
Group Name :
Keywords :
PNMP, NSAID, osteoarthritis, rheumatic disease, musculoskeletal pain
Brand Names Include :
Naprosyn
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Naproxen is used to treat.

Committee Recommendations (1)

A stepped approach to pain management is recommended. Paracetamol is considered a 1st line option for the treatment of pain. Consider initiation of an oral NSAID as an adjunct to paracetamol if required. See the guidelines attached for further information.

PLEASE NOTE: Naproxen effervescent tablets or naproxen oral suspension, should only be used where a patient with swallowing difficulties caanot tolerate ibuprofen suspension or ibuprofen suspension is ineffective.